Developing a vaccine against Chagas disease
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
A collaborative research team led by Dr. Philip Li from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has pioneered a new nurse-led penicillin allergy triage and testing strategy—the Hong Kong Drug Allergy ...
Nov 28, 2022
0
7
Care from an allergist is associated with a reduction in total health care costs for U.S. children with peanut allergy, new research finds.
Oct 24, 2022
0
3
In a new article published Oct. 13 in the journal Science, Megan Sykes, the Michael J. Friedlander Professor of Medicine and professor of microbiology and immunology and surgical sciences (in surgery) and director of Columbia's ...
Oct 21, 2022
0
2
A collaborative effort between investigators at Roswell Park Comprehensive Cancer Center and the Center for Molecular Immunology (CIM) in Havana, Cuba, has revealed a new strategy for correcting immune dysfunction in cancer ...
Oct 6, 2022
0
52
A new guideline published in Clinical & Experimental Allergy will help clinicians evaluate and test patients for potential penicillin allergies.
Sep 21, 2022
0
13
Scientists believe natural-killer cells in the liver may explain why liver transplant patients typically require less treatment with immunosuppressant drugs to prevent rejection than recipients of other organ transplants.
Jul 27, 2022
0
21
Researchers at the Allen Institute for Immunology have been busy. Since the division of the Allen Institute launched in late 2018, the 60-person team of immunologists, molecular and computational biologists, engineers and ...
Jun 1, 2022
0
20
Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment. However, there still exists an unmet medical need due to the low response ...
May 31, 2022
0
9
In the fight against cancer, a new tool has emerged that's shifted the treatment landscape. CAR T-cell therapy, first approved for clinical use in 2017, uses a patient's own re-engineered immune cells to attack cancer. It ...
May 17, 2022
0
14